newsfilter
← Latest News
PR Newswire·

Spirovant Launches State-of-the-Art Laboratory and Headquarters

The facilities are located in the center of Philadelphia's thriving life sciences corridor PHILADELPHIA, May 16, 2022 /PRNewswire/ -- Spirovant Sciences, a gene therapy company developing treatments for respiratory diseases, including cystic fibrosis (